Azurix, 80 mg 30 pcs

Uric acid is the end product of purine metabolism in humans and is formed by the following reaction: hypoxanthine → xanthine → uric acid. Xanthine oxidase is a catalyst for both steps of this reaction. Febuxostat is a 2-arylthiazole derivative. Its therapeutic effect is associated with reduction of uric acid concentration in blood serum through selective inhibition of xanthine oxidase.

Indications

Active ingredient

How to take, the dosage

Interaction

Contraindications

Side effects

Overdose

Similarities